AzTrials
AzTrials

Suicide PreventionNCT06130943

Evaluation of the Quality of Telephone Calls to a Suicide Prevention Helpline

An observational study of Suicide Prevention and Suicidal Ideation, run by University Ghent at 1 site in Belgium.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study adds to the existing evidence on suicide prevention helpline efficacy because it tackles some of the common limitations for helpline studies. High risk individuals were not excluded from the study, since there was no human interference in deciding if the study was offered to the lifeline callers. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Suicide Prevention, Suicidal Ideation
How many people
608 participants
Where
1 siteBelgium
Study dates
12 Oct 2020to 14 Dec 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: All callers who contact the suicide prevention helpline are asked to participate in the study.

Who may be able to join

  • being 18 years of age or older
  • Dutch-speaking
  • calling to the Flemish suicide prevention helpline because they felt suicidal
  • Only callers for whom it is certain that they will be connected to the Flemish suicide prevention helpline will be asked to participate.

Who cannot join

  • Third party callers were excluded

Trial locations and contacts

1 site in 1 country.

Belgium1 site
  • Centre for Suicide Prevention

    Brussels

Other trials in Belgium

About this study

This study adds to the existing evidence on suicide prevention helpline efficacy because it tackles some of the common limitations for helpline studies. High risk individuals were not excluded from the study, since there was no human interference in deciding if the study was offered to the lifeline callers. Most of the existing studies exclude users in high risk and acute crisis situations. The study employed the callers' own ratings on a set of questions, automatically offered within the phone system immediately before and after the call to assess the immediate impact of the call and the intervention. The automatization of the self-report measures in the telephone system reduces the burden on the operators to offer the research questions without interrupting the crisis intervention and decreases the risk of bias in caller responses.

The goal of this observational study is to evaluatie the Flesmish suicide prevention helpline in people who call the helpline when feeling suicidal. The main questions it aims to answer are:

Read more
  1. Has the degree to which the caller feels in crisis subsided? (Crisis in this is seen as the subjective feeling of complete emotional upset)
  2. Does the caller report feeling less suicidal? (Score on selected indicators of suicidality, particularly hopelessness, entrapment, controllability, suicidal intent and social support)
  3. Is the caller satisfied with the conversation?
  4. Which elements in the conversation (i.e., responders' interventions) make it more or less effective, in terms of crisis level, suicidality (indicators) and caller satisfaction?
  5. Which elements of the conversation do callers name as (not) helpful during the follow-up conversation? Which elements promoted progress in this, besides merely lowering the crisis level?
  6. What possible (follow-up) actions do callers see as helping to sustain and/or improve the longer-term impact of the conversation with the suicide prevention helpline?

Participants are asked the fill in items before the call, immediately after the call and one to two weeks after the call.

Read the detailed description

All adult (18+) callers who contact the suicide prevention helpline are offered the opportunity to participate in the study, once per (coded) phone number. The study is presented to the caller before there is any interaction between the caller and the operator and only when an operator is immediately available to answer the call. Informed consent is acquired in two steps, in order to minimise the time between calling and being transferred to the operator for callers not wanting to participate in the study: callers are asked if they are interested in taking part in the research: if not, they are transferred immediately to the operator; if they indicated being interested they receive more information about the study. The information about the study, which is recorded, is given automatically by the telephone system. Callers can consent by using the telephone keypad. More detailed information about the study is available for them on the website of the helpline.

After consenting, participants are asked about their age and gender and to respond to six short statements on their state of crisis and suicidality. All questions are answered using the telephone keys. After completing the questionnaire, or whenever they want to discontinue the study, participants are immediately transferred to the operator.

At the end of the call, a post-test is offered to the participants using the automatic telephone system. The six statements on the state of crisis and suicidality are assessed again, in addition a question on the degree of satisfaction with the call. After completing the post-test participants are asked whether they want to participate in the follow-up study. In order to contact them a phone number on which they can be contacted after one to two weeks, is asked. This phone number is coded by the phone system in order to guarantee the anonymity of the participant.

One to two weeks after contacting the helpline, a follow-up interview is conducted. This interview is carried out by an interviewer with extensive training in crisis calls. After making an initial contact with the participant, the six statements on the state of crisis and suicidality and the satisfaction about the call are assessed again automatically.

Medical subject headings
Suicide Prevention, Suicidal Ideation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Indicatorts of crisis and suicidality

    Since there is no common standardized set of measures for suicide prevention helplines (Mazzer et al., 2021; Trail et al., 2022) six indicators of suicidal ideation and behaviour (SIB) are used to evaluate the calls of the Flemish Suicide Prevention Helpline. The selection of the indicators is based on previous research on helpline efficacy (Gould et al., 2007; Hoffberg et al., 2020; Hvidt et al., 2016; Kalafat et al., 2007), and on a number of core elements identified in suicide prevention theories explaining the transition from suicidal ideation to suicidal behaviour. The six indicators are crisis, hopelessness, entrapment, controllability, suicidal intent, and social support. All indicators are scored by the callers on a 10-point Likert scale (using the telephone keypad), ranging from 0 (not at all) to 9 (totally).

    Measured: Baseline, post (immediately after the call), follow-up (one to two weeks after the call)

Secondary outcomes (1)
  1. Satisfaction with the service

    The satisfaction of the caller is assessed by the question 'I am satisfied about the call I just had with the suicide prevention helpline'.

    Measured: Post (immediately after the call), follow-up (one to two weeks after the call)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Nov 2023
  2. Study start12 Oct 2020
  3. Primary completion4 Dec 2021
  4. Study completion14 Dec 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
608 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06130943
Sponsor's protocol ID
B6702020000210
Status last verified
Nov 2023
First submitted
8 Nov 2023
Last updated
18 Nov 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Suicide Prevention and Suicidal Ideation, run by University Ghent at 1 site in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Nov 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Indicatorts of crisis and suicidality (time frame: Baseline, post (immediately after the call), follow-up (one to two weeks after the call)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Nov 2023; AzTrials last refreshed its copy on 8 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in